A lawsuit accuses WPATH of making deceptive claims about transgender medical “treatments” for minors, minimizing the ethical and safety risks of such interventions.
| PULSE POINTS |
❓ WHAT HAPPENED: The Federal Trade Commission (FTC) and four Republican-led states have filed a lawsuit against the World Professional Association for Transgender Health (WPATH), alleging the organization misled parents and doctors about the safety and effectiveness of transgender “treatments” for minors. The suit claims WPATH made deceptive assertions regarding puberty blockers, cross-sex hormones, and surgeries while failing to adequately disclose risks. 📺 DETAIL: The complaint alleges the group removed age-based recommendations from its standards of care and promoted treatments not adequately supported by evidence. FTC Chairman Andrew Ferguson said parents have a right to make informed healthcare decisions for their children and accused medical organizations of prioritizing profit over safety. The lawsuit is part of the Trump administration’s broader effort to scrutinize medical interventions for transgender minors. WPATH rejected the allegations, arguing the FTC’s actions are retaliatory and part of a broader campaign to undermine so-called gender-affirming care and the independence of the medical organizations that promote it. 💬 KEY QUOTE: “Parents have a right to make informed decisions about their children’s health. The FTC will not allow parents and children to be deceived by medical organizations and providers who are prioritizing profit over children’s health and safety.” – FTC Chairman Andrew Ferguson 🎯 IMPACT: This lawsuit highlights the growing scrutiny of life-altering medical interventions for supposedly transgender minors. The case also underscores broader national debates over the role of organizations like WPATH in promoting controversial “treatments.” 📺 FLASHBACK: WPATH previously argued that the FTC’s investigation was an attack on its First Amendment rights. This legal clash follows years of intensifying debate over taxpayer funding for gender-related medical procedures and the ethical problems with applying such treatments for minors, inflicting irreparable harm at a stage in their lives when they are too immature to make informed decisions. |
Join Pulse+ to comment below, and receive exclusive e-mail analyses.
show less
